195 related articles for article (PubMed ID: 28647344)
21. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
Deffrennes V; Vedrenne J; Stolzenberg MC; Piskurich J; Barbieri G; Ting JP; Charron D; Alcaïde-Loridan C
J Immunol; 2001 Jul; 167(1):98-106. PubMed ID: 11418637
[TBL] [Abstract][Full Text] [Related]
22. Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.
Kaplon J; Hömig-Hölzel C; Gao L; Meissl K; Verdegaal EM; van der Burg SH; van Doorn R; Peeper DS
Pigment Cell Melanoma Res; 2014 Jul; 27(4):640-52. PubMed ID: 24703243
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
Lee WJ; Škalamera D; Dahmer-Heath M; Shakhbazov K; Ranall MV; Fox C; Lambie D; Stevenson AJ; Yaswen P; Gonda TJ; Gabrielli B
SLAS Discov; 2017 Mar; 22(3):298-308. PubMed ID: 27872202
[TBL] [Abstract][Full Text] [Related]
24. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.
Leikam C; Hufnagel A; Schartl M; Meierjohann S
Oncogene; 2008 Nov; 27(56):7070-82. PubMed ID: 18806824
[TBL] [Abstract][Full Text] [Related]
25. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
Elife; 2020 Oct; 9():. PubMed ID: 33047672
[TBL] [Abstract][Full Text] [Related]
27. Coordinated post-transcriptional control of oncogene-induced senescence by UNR/CSDE1.
Avolio R; Inglés-Ferrándiz M; Ciocia A; Coll O; Bonnin S; Guitart T; Ribó A; Gebauer F
Cell Rep; 2022 Jan; 38(2):110211. PubMed ID: 35021076
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
29. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
30. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
31. Protooncogene MYC drives human melanocyte melanogenesis and senescence.
San Juan L; Cagigal ML; Fernandez-Flores A; Mayorga M; Gandarillas A
Cancer Gene Ther; 2022 Aug; 29(8-9):1160-1167. PubMed ID: 35022520
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional landscape of oncogene-induced senescence: a machine learning-based meta-analytic approach.
Han Y; Micklem G; Kim SY
Ageing Res Rev; 2023 Mar; 85():101849. PubMed ID: 36621646
[TBL] [Abstract][Full Text] [Related]
33. Role of the Skin Microenvironment in Melanomagenesis: Epidermal Keratinocytes and Dermal Fibroblasts Promote BRAF Oncogene-Induced Senescence Escape in Melanocytes.
Sadangi S; Milosavljevic K; Castro-Perez E; Lares M; Singh M; Altameemi S; Beebe DJ; Ayuso JM; Setaluri V
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267541
[No Abstract] [Full Text] [Related]
34. Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.
Xie X; Koh JY; Price S; White E; Mehnert JM
Cancer Discov; 2015 Apr; 5(4):410-23. PubMed ID: 25673642
[TBL] [Abstract][Full Text] [Related]
35. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.
Bradley SD; Chen Z; Melendez B; Talukder A; Khalili JS; Rodriguez-Cruz T; Liu S; Whittington M; Deng W; Li F; Bernatchez C; Radvanyi LG; Davies MA; Hwu P; Lizée G
Cancer Immunol Res; 2015 Jun; 3(6):602-9. PubMed ID: 25795007
[TBL] [Abstract][Full Text] [Related]
36. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
[TBL] [Abstract][Full Text] [Related]
37. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
38. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
39. Oncogene-induced senescence results in marked metabolic and bioenergetic alterations.
Quijano C; Cao L; Fergusson MM; Romero H; Liu J; Gutkind S; Rovira II; Mohney RP; Karoly ED; Finkel T
Cell Cycle; 2012 Apr; 11(7):1383-92. PubMed ID: 22421146
[TBL] [Abstract][Full Text] [Related]
40. Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
Eberle J; Garbe C; Kroumpouzos G; Orfanos CE
Recent Results Cancer Res; 1995; 139():123-35. PubMed ID: 7597285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
